Pain relievers and psilocybin.
39 records in this group. 1 has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as pain reliever · painkiller · painkillers · pain medication · pain medicine · pain pill · pain pills · pain med · analgesic
01 What the evidence covers
Best evidence available per medication| 1 | Case reports Case reports or online surveys |
| 38 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZMinor aches and pains (such as headache, toothache, backache, muscle aches, colds); Fever
Not studied with psilocybin; no linking mechanism is described.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- Acetaminophen–aspirin–caffeine · Excedrin Extra Strength, Excedrin MigraineEvidence: No psilocybin data
Minor aches and pains (headache, colds, arthritis, muscular aches, toothache, menstrual cramps); Migraine
Its caffeine may add to psilocybin's brief rise in heart rate. Acetaminophen and aspirin are not studied with psilocybin.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Tension (muscle contraction) headache
Its barbiturate sedation may add to psilocybin's effects. Stopping it suddenly after regular use can cause seizures.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Mild to moderate pain (when an opioid is appropriate)
Its sedation and nausea may add to psilocybin's nausea. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Occasional headaches and minor aches and pains with accompanying sleeplessness
It causes drowsiness and may cause confusion with psilocybin. The acetaminophen part has no known psilocybin interaction.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Minor aches and pains (headache, muscle pain, toothache, menstrual pain, arthritis); Fever
Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, more so with blood thinners or steroids.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Opioid use disorder (opioid dependence)
In two people on buprenorphine, psilocybin was tolerated without serious events. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- ButorphanolEvidence: No psilocybin data
Pain severe enough to require an opioid when other treatments are inadequate; Before surgery or anesthesia, and as a supplement to balanced anesthesia (injection)
Its label reports possible unpleasant dreamlike mental effects, which may add to psilocybin's. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Osteoarthritis; Rheumatoid arthritis
Not studied with psilocybin. Also, long-term use can raise blood pressure, and its label has a boxed warning for heart attack and stroke.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- CodeineEvidence: No psilocybin data
Mild to moderate pain when an opioid is appropriate
Its sedation and nausea may add to psilocybin's nausea. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Osteoarthritis; Rheumatoid arthritis
Lab studies suggest it may slow how the body clears psilocybin (not shown in people), and its blood pressure rise may add to psilocybin's.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Severe long-term pain in opioid-tolerant patients
This opioid can slow breathing and psilocybin does not; serotonin effects may add. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Pain severe enough to require an opioid
Its sedation and nausea may add to psilocybin's; its breathing risk rises with other sedatives. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Severe pain requiring an opioid when other treatments are inadequate
It may add nausea to psilocybin's and causes sedation and slowed breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Minor aches and pains (headache, toothache, backache, muscle aches, minor arthritis pain, colds); Menstrual cramps
Not studied with psilocybin. Also, daily use can raise blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Occasional sleeplessness associated with minor aches and pains
Its diphenhydramine causes drowsiness and may cause confusion under psilocybin. Also, regular ibuprofen use can raise blood pressure, as psilocybin briefly does.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Rheumatoid arthritis; Ankylosing spondylitis
Not studied with psilocybin; it can raise blood pressure, so a combined rise is possible. Also, it may worsen depression and rarely cause psychotic episodes.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Short-term (up to 5 days) moderately severe acute pain
Not studied with psilocybin, and no effect on how the body clears psilocybin has been identified.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- LevorphanolEvidence: No psilocybin data
Pain severe enough to require an opioid when other treatments are inadequate
Its sedation and nausea may add to psilocybin's; it can slow breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- LidocaineEvidence: No psilocybin data
Pain after shingles (post-herpetic neuralgia) (5% patch); Local or regional anesthesia by infiltration or peripheral nerve block (injection)
Not studied with psilocybin; no linking mechanism is described. Also, skin forms are barely absorbed; high blood levels from injection can cause confusion or seizures.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Mild to moderate pain (short-term, up to 1 week); Menstrual cramps (primary dysmenorrhea)
In lab studies it slowed how the body clears psilocybin, so it may raise psilocybin levels and add to its blood pressure rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Osteoarthritis; Rheumatoid arthritis
Not studied with psilocybin; no linking mechanism is described. Also, long-term use can raise blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
Not studied with psilocybin; both parts can raise blood pressure and one acts on serotonin, so added effects are possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Severe pain requiring an opioid; Pain control before and during surgery (preoperative medication, anesthesia support)
Not studied with psilocybin; it has serotonin-boosting activity, so added serotonin effects are possible. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Severe, persistent pain requiring an opioid; Opioid use disorder (detoxification and maintenance treatment)
Not studied with psilocybin; it is sedating and mildly serotonin-boosting, so added effects are possible. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Severe, persistent pain requiring an opioid when alternatives (including immediate-release opioids) are inadequate (extended-release tablets); Pain severe enough to require an opioid when alternatives are inadequate (injection)
Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Osteoarthritis (signs and symptoms); Rheumatoid arthritis (signs and symptoms)
Not studied with psilocybin; no linking mechanism is described. Also, long-term use can cause or worsen high blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- NalbuphineEvidence: No psilocybin data
Pain severe enough to require an opioid when other treatments are inadequate; Supplement to balanced anesthesia
Not studied with psilocybin; it is sedating and its label reports hallucinations, so added effects are possible. Also, it can trigger opioid withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Minor aches and pains (headache, toothache, backache, muscle aches, minor arthritis pain, colds); Menstrual cramps
Not studied with psilocybin; no linking mechanism is described. Also, daily use can raise blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Occasional sleeplessness associated with minor aches and pains
It causes drowsiness and may cause confusion with psilocybin; regular naproxen use can raise blood pressure, as psilocybin briefly does.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute pain severe enough to require an intravenous opioid when other treatments are inadequate (adults)
Not studied with psilocybin; this hospital opioid sedates and slows breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Pain severe enough to require an opioid when other treatments are inadequate (immediate-release); Severe, persistent pain needing long-term daily opioid treatment (extended-release)
Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Pain severe enough to require an opioid when other treatments are inadequate
Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- OxymorphoneEvidence: No psilocybin data
Acute pain severe enough to require an opioid when other treatments are inadequate (immediate-release); Severe, persistent pain needing an opioid that other options cannot treat (extended-release)
Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- Pentazocine (with naloxone)Evidence: No psilocybin data
Pain severe enough to require an opioid when other treatments are inadequate
Not studied with psilocybin. Its label reports hallucinations and raised blood pressure, so added effects on perception and blood pressure are possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute treatment of migraine with or without aura (adults and children 12 and older)
Sumatriptan's serotonin activity may add to psilocybin's effects and brief blood pressure rise. Also, its label reports rare significant blood pressure rises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Moderate to severe acute pain in adults
Not studied with psilocybin; it speeds up an enzyme that helps clear psilocybin, so slightly lower levels are possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute pain severe enough to require an opioid; Severe persistent pain requiring an opioid (extended-release)
It may add serotonin effects to psilocybin and make seizures more likely. As an opioid it causes sedation and slowed breathing, which psilocybin does not.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Pain severe enough to require an opioid (adults)
It may add serotonin effects to psilocybin or weaken it, and can cause seizures. As an opioid, it slows breathing; psilocybin does not.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 23 | Sedating or CNS depressant |
| 21 | Serotonergic |
| 20 | Lowers seizure threshold or carries seizure risk |
| 20 | Withdrawal or rebound if stopped abruptly |
| 19 | Lowers blood pressure or causes orthostasis |
| 19 | Opioid |
| 15 | Raises blood pressure or heart rate |
| 9 | Liver injury |
| 4 | Psychiatric reactions |
| 3 | Anticholinergic |
| 3 | Opioid blocker |
| 3 | QT-prolonging |
| 1 | Dehydration or electrolyte risk |
| 1 | Hypoglycemia risk |
| 1 | Slows gastric emptying |
| 1 | Speeds up drug metabolism |
| 1 | UGT inhibition (theoretical effect on psilocin levels) |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 1 of the 39 medications in this group is psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRelated classes
- Opioids and opioid pain medications19 shared
- Antihistamines and allergy pills3 shared
- Migraine medications3 shared
- Sleep medications3 shared
Records reviewed 2026-09-30 to 2026-10-25. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z